×

Warning

JUser: :_load: Unable to load user with ID: 18050

Germline Mutations in Prostate Cancer - Salvatore Catarinicchia

Salvatore Pietro Catarinicchia M.D., Urology Resident Physician at the University of Colorado, discusses the latest evidence on "Germline mutations in ATM and BRCA1/2 genes could help predict death risk from aggressive prostate cancer" with E. David Crawford, MD. During their dialogue, Dr. Crawford shares a recent patient experience with Dr. Catarinicchia that demonstrates the clinical implications of genetic testing in urology practices based on the patient’s family history.

Read: Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer.Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer.

Read: Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer.


E-Newsletters

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.

Subscribe